Abiopharma

CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026

Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy

Federal Signal Reports Record Second Quarter Results Including 19% Net Sales Growth, 21% Operating Income Improvement, Strong Cash Generation, and 18% Increase in Orders; Raises Full-Year Outlook

PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026

Century Casinos Announces Dates of Second Quarter 2026 Earnings Release and Conference Call

Exyn Technologies Demonstrates Power of Autonomous Mining with Major Productivity Gains at Eldorado Golds Tüprag Mine in Turkey

Gentherm Announces Participation in J.P. Morgan Auto Conference and Seaport Annual Summer Investor Conference

Abercrombie & Fitch Returns to its New York Roots with Fall Denim Campaign

ASP Isotopes to Participate in Canaccord Genuity’s 46th Annual Growth Conference on August 12, 2026

OPAL Fuels to Supply Municipal Refuse Fleet with Renewable Natural Gas Across California’s Central Valley